These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24523121)

  • 1. Sources of interindividual variability.
    Thummel KE; Lin YS
    Methods Mol Biol; 2014; 1113():363-415. PubMed ID: 24523121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of Interindividual Variability.
    Lin YS; Thummel KE; Thompson BD; Totah RA; Cho CW
    Methods Mol Biol; 2021; 2342():481-550. PubMed ID: 34272705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic changes in gene expression for drug-metabolizing enzymes and transporters.
    Kim IW; Han N; Burckart GJ; Oh JM
    Pharmacotherapy; 2014 Feb; 34(2):140-50. PubMed ID: 24166985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics: has it reached the clinic?
    Schwartz JB
    J Gend Specif Med; 2002; 5(2):13-8. PubMed ID: 11974670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.
    Hines RN
    Int J Pharm; 2013 Aug; 452(1-2):3-7. PubMed ID: 22766445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE; Johnson JA
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
    Johnson AD; Wang D; Sadee W
    Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
    Zanger UM; Schwab M
    Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD; Lee YB
    Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.
    Alshogran OY
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1063-1073. PubMed ID: 28871815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental pharmacogenomics.
    Neville KA; Becker ML; Goldman JL; Kearns GL
    Paediatr Anaesth; 2011 Mar; 21(3):255-65. PubMed ID: 21320234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.